138 related articles for article (PubMed ID: 14660053)
1. Interleukin-12 and interleukin-18 change ICAM-I expression, and enhance natural killer cell mediated cytolysis of human osteosarcoma cells.
Liebau C; Merk H; Schmidt S; Roesel C; Karreman C; Prisack JB; Bojar H; Baltzer AW
Cytokines Cell Mol Ther; 2002; 7(4):135-42. PubMed ID: 14660053
[TBL] [Abstract][Full Text] [Related]
2. IL-18-induced expression of intercellular adhesion molecule-1 in human monocytes: involvement in IL-12 and IFN-gamma production in PBMC.
Yoshida A; Takahashi HK; Nishibori M; Iwagaki H; Yoshino T; Morichika T; Yokoyama M; Kondo E; Akagi T; Tanaka N
Cell Immunol; 2001 Jun; 210(2):106-15. PubMed ID: 11520077
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma.
Liebau C; Baltzer AW; Schmidt S; Roesel C; Karreman C; Prisack JB; Bojar H; Merk H
Anticancer Res; 2002; 22(2A):931-6. PubMed ID: 12014674
[TBL] [Abstract][Full Text] [Related]
4. Ligation of ICAM-1 molecules inhibits target cell-induced granule exocytosis of IL-12-activated natural killer cells.
Cho DH; Song HK; Kang HS; Yoon SR; Lee HG; Pyun KH; Lee WJ; Kim YB; Choi I
Cell Immunol; 2000 Jan; 199(1):1-7. PubMed ID: 10675269
[TBL] [Abstract][Full Text] [Related]
5. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.
van de Wetering D; de Paus RA; van Dissel JT; van de Vosse E
Int Immunol; 2009 Feb; 21(2):145-53. PubMed ID: 19088061
[TBL] [Abstract][Full Text] [Related]
6. A novel role for interleukin-18 in human natural killer cell death: high serum levels and low natural killer cell numbers in patients with systemic autoimmune diseases.
Shibatomi K; Ida H; Yamasaki S; Nakashima T; Origuchi T; Kawakami A; Migita K; Kawabe Y; Tsujihata M; Anderson P; Eguchi K
Arthritis Rheum; 2001 Apr; 44(4):884-92. PubMed ID: 11315928
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
[TBL] [Abstract][Full Text] [Related]
9. Magnetically labeled human natural killer cells, accumulated in vitro by an external magnetic force, are effective against HOS osteosarcoma cells.
Nakashima Y; Deie M; Yanada S; Sharman P; Ochi M
Int J Oncol; 2005 Oct; 27(4):965-71. PubMed ID: 16142312
[TBL] [Abstract][Full Text] [Related]
10. NK cell depletion results in accelerated tumor growth and attenuates the antitumor effect of total body irradiation.
Miller GM; Andres ML; Gridley DS
Int J Oncol; 2003 Dec; 23(6):1585-92. PubMed ID: 14612930
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells.
Son YI; Dallal RM; Mailliard RB; Egawa S; Jonak ZL; Lotze MT
Cancer Res; 2001 Feb; 61(3):884-8. PubMed ID: 11221875
[TBL] [Abstract][Full Text] [Related]
12. Interleukin (IL)-12 and IL-12 gene transfer up-regulate Fas expression in human osteosarcoma and breast cancer cells.
Lafleur EA; Jia SF; Worth LL; Zhou Z; Owen-Schaub LB; Kleinerman ES
Cancer Res; 2001 May; 61(10):4066-71. PubMed ID: 11358827
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma-induced intercellular adhesion molecule-1: expression on human tumor cells enhances bifunctional antibody-mediated lysis through a lymphocyte function-associated antigen-1 dependent mechanism.
Ramsey PS; Dean PA; Tasimowicz-Alpini A; Donohue JH; Nelson H
Cancer Res; 1993 Oct; 53(19):4652-7. PubMed ID: 8104686
[TBL] [Abstract][Full Text] [Related]
14. An in vitro coculture model to study cytokine profiles of natural killer cells during maternal immune cell-trophoblast interactions.
Ntrivalas E; Kwak-Kim J; Beaman K; Mantouvalos H; Gilman-Sachs A
J Soc Gynecol Investig; 2006 Apr; 13(3):196-202. PubMed ID: 16516503
[TBL] [Abstract][Full Text] [Related]
15. Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells.
Bontkes HJ; Kramer D; Ruizendaal JJ; Meijer CJ; Hooijberg E
Clin Immunol; 2008 Jun; 127(3):375-84. PubMed ID: 18358784
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-18 restores immune suppression in patients with nonseptic surgery, but not with sepsis.
Hiraki S; Ono S; Kinoshita M; Tsujimoto H; Seki S; Mochizuki H
Am J Surg; 2007 Jun; 193(6):676-80. PubMed ID: 17512275
[TBL] [Abstract][Full Text] [Related]
17. Genetic background influences natural killer cell activation during bacterial peritonitis in mice, and is interleukin 12 and interleukin 18 independent.
Scott MJ; Hoth JJ; Gardner SA; Peyton JC; Cheadle WG
Cytokine; 2004 Nov; 28(3):124-36. PubMed ID: 15473954
[TBL] [Abstract][Full Text] [Related]
18. Clones derived from human natural killer cells are susceptible to lysis by human interleukin-2-activated killer cells.
Fujiwara T; Loudon WG; Grimm EA
Lymphokine Cytokine Res; 1993 Feb; 12(1):45-8. PubMed ID: 8096153
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection.
Scott MJ; Hoth JJ; Turina M; Woods DR; Cheadle WG
Cytokine; 2006 Jan; 33(2):79-86. PubMed ID: 16488621
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cell surface markers on NK-like T lymphocytes by using IL-2, IL-7 or IL-12 in vitro stimulation.
Zoll B; Lefterova P; Ebert O; Huhn D; Von Ruecker A; Schmidt-Wolf IG
Cytokine; 2000 Sep; 12(9):1385-90. PubMed ID: 10975999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
